Meda AB

Type: Company
Name: Meda AB
Nationality: Sweden
Web Address: http://www.meda.se/
Fact Sheet: Fact Sheet for Meda AB
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Meda posts net profit of SEK503m in January to June 2014

(M2 EQUITYBITES via COMTEX News Network) -- Specialty pharmaceutical company Meda AB (STO:MEDAA) on Wednesday reported profit after tax of SEK503m, or EPS of SEK1.66, for the six month period of January 2014 to June 2014.This was an increase over profit ... [Published PredictWallStreet - Aug 14 2014]
First reported Aug 13 2014 - Updated Aug 14 2014 - 2 reports

Treasuries Rise While Emerging-Market Stocks Gain, Copper Slumps

Aug. 13 (Bloomberg) -- Treasuries rose as data showed retail sales were little changed in July. Stocks advanced, led by a rally in emerging markets, amid bets China will take steps to support economic growth following weaker factory output.Yields on 10-year ... [Published Washington Post - Aug 13 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Meda Falls Most Since Rejecting Mylan on Lowered Sales Forecast

Meda AB (MEDAA) , the Swedish drugmakerbuying Rottapharm Madaus of Italy after spurning a takeover bidfrom Mylan Inc. (MYL) , fell the most in three months after cutting itssales forecast on difficulties manufacturing a skin treatment.Meda now sees organic ... [Published Bloomberg - Aug 13 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Meda pays SEK21bn for family owned Italian company Rottapharm

Deal Date: Jul-01-2014 /Deal # 201410128Executive SummaryMeda AB , which recently fought off two unsolicited takeover bids from Mylan Inc. (the latest of which would have valued Meda at $6.7bn), paid SEK21bn ($3.1bn) for private, family owned Italian ... [Published Health News Daily - Aug 13 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Interim Report, January-June 2014

I am satisfied with our performance during the second quarter as we have continued to deliver healthy organic growth. Sales were up 6% in the second quarter, corresponding to organic growth of 4%. The EBITDA margin was 28.6% in Q2 and 29.3% for the first ... [Published Noodls - Aug 13 2014]
Entities: Organic, Meda AB, Elidel
First reported Aug 11 2014 - Updated Aug 11 2014 - 1 reports

Why is part of Main Cross closed?

Q: Findlay’s East Main Cross Street, between Osborn Avenue and Blanchard Street, has been closed for several weeks. Construction equipment is there. What’s being done, and when will it be finished? — Steve Schroeder, Findlay.A: The bridge over Lye Creek ... [Published Findlay Courier - Aug 11 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

MEDA: Invitation to Teleconference for Analysts, Investors and Journalists

On Wednesday, August 13th, 2014 at 8:00 CET, Meda (STO:MEDAA) willrelease its second quarter results for 2014. Meda invites all analysts,investors and media to a teleconference to be held on Wednesday, August13th at 10:30 CET.During the teleconference, ... [Published Tamar Securities - Aug 06 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

Meda to acquire 100% stake in Rottapharm

Meda AB, a Sweden-based pharmaceutical company, has entered into a definitive agreement to acquire 100% stake in Rottapharm SpA, an Italy-based pharmaceutical company engaged in research, development, manufacturing, and distribution of branded consumer ... [Published Individual.com - Aug 01 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 2 reports

Meda Buys Rottapharm for $3.1B

Meda said today it will buy Rottapharm Madaus for SEK 21.2 billion (about $3.1 billion) from Italy’s Rovati family, in a deal the buyer said reflected its desire to grow into a leading specialty pharma through acquisitions—namely by combining the seller’s ... [Published Genetic Engineering News - Jul 31 2014]
First reported Jul 31 2014 - Updated Jul 31 2014 - 5 reports

Derivatives: Anticipated adjustment due to rights issue in Meda (58/14)

The following information is based on a press release from Meda AB (Meda) published on July 31, 2014 and may be subject to change. The board of Meda plans a rights issue for existing shareholders, which is expected to be proposed to an Extraordinary General ... [Published Street Sweeper - Jul 31 2014]
Entities: Meda AB
First reported Jul 18 2014 - Updated Jul 18 2014 - 2 reports

Shire Agrees to AbbVie $55B Takeover Offer

07/18/14 - 10:37 AM EDTLONDON ( The Deal ) -- AbbVie ( ABBV ) forged a 32 billion pounds ($54.7 billion) takeover deal for Shire ( SHPG ) Friday, having agreed to a $500 million-plus, one-way breakup fee amid concerns a potential U.S. clampdown on companies ... [Published TheStreet.com - Jul 18 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 2 reports

MEDA: Nomination Committee’s Proposal for Composition of the Board

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): The Nomination Committee of Meda AB proposes the election of Guido Oelkers and Martin Svalstedt as new board members and proposes the appointment of Martin Svalstedt as Board Chairman. ... [Published Business Wire Health News - Mar 28 2014]

Quotes

...Andrew Finn , Executive Vice President of Product Development. "We will continue to work closely with our partner Endo Pharmaceuticals as they prepare the NDA submission for late this year or early next year."
...Mark A Sirgo, President and Chief Executive Officer. "Based on this information we will continue to progress other aspects of the clinical development program necessary for the NDA."
...Luca Rovati, CEO of Rottapharm. "We are now ready to take the next step. We are very pleased to have reached this agreement with Meda and are confident that this will create significant value in the long-term for all our stakeholders. Through Meda's expertise and resources, we are also confident that our medications will continue to serve patients and doctors alike going forward. Also, I very much look forward to contributing to the future success of the combined business as second largest shareholder in Meda." Enhanced scale, reach and profitability
"Tax is clearly a benefit but it's not the primary rationale," he added. "My own point of view is the debate would be more appropriately shifted to tax reform. Companies like ours need access to our global cash flows and today we are at a disadvantage compared to our competitors."

More Content

All (57) | News (32) | Reports (0) | Blogs (15) | Audio/Video (0) | Fact Sheets (2) | Press Releases (8)
sort by: Date | Relevance
Cipla's Q1 misses street expectations [Published Business Standard India - Aug 14 2014]
Meda posts net profit of SEK503m in January to ... [Published PredictWallStreet - Aug 14 2014]
Treasuries Rise While Emerging-Market Stocks Ga... [Published Washington Post - Aug 13 2014]
Treasuries Rise on Retail Sales; Stocks Gain as... [Published Washington Post - Aug 13 2014]
European Stocks Rise as EON, Swiss Life Earning... [Published Washington Post - Aug 13 2014]
Meda Falls Most Since Rejecting Mylan on Lowere... [Published Bloomberg - Aug 13 2014]
Meda pays SEK21bn for family owned Italian comp... [Published Health News Daily - Aug 13 2014]
Interim Report, January-June 2014 [Published Noodls - Aug 13 2014]
Trending Now: Inversions & Hating Them [Published Forbes.com - Aug 13 2014]
BioDelivery Sciences Announces BEMA Buprenorphi... [Published Barchart - Aug 12 2014]
Why is part of Main Cross closed? [Published Findlay Courier - Aug 11 2014]
BioDelivery Sciences Provides Update on Ongoing... [Published TickerTech.com - Aug 06 2014]
MEDA: Invitation to Teleconference for Analysts... [Published Tamar Securities - Aug 06 2014]
Meda to acquire 100% stake in Rottapharm [Published Individual.com - Aug 01 2014]
Meda Buys Rottapharm for $3.1B [Published Genetic Engineering News - Jul 31 2014]
Derivatives: Anticipated adjustment due to righ... [Published Street Sweeper - Jul 31 2014]
Why Pharma Companies Are Rushing To Relocate Ov... [Published Bidness Etc - Jul 31 2014]
Meda to buy drugs maker Rottapharm for $3.08 bi... [Published Morningstar.com - Jul 31 2014]
The Wall Street Journal: Meda to buy drugs make... [Published Austin American Statesman - Jul 31 2014]
Meda buys Italian pharma firm [Published Seeking Alpha - Jul 31 2014]
Meda To Buy Rottapharm For SEK 21.2 Bln On Cash... [Published RTTNews.com - Jul 31 2014]
Meda to acquire Rottapharm, creating a European... [Published Noodls - Jul 31 2014]
BioDelivery Sciences Appoints Charles J. Bramla... [Published Scottrade - Jul 22 2014]
Shire Agrees to AbbVie $55B Takeover Offer [Published TheStreet.com - Jul 18 2014]
Shire Agrees to AbbVie $55B Takeover Offer [Published The Street Latest - Jul 18 2014]
Mission Pharmacal starts promotion of Elestrin ... [Published PharmaBiz - May 31 2014]
Mission Pharmacal Begins Exclusive Promotion of... [Published PR Newswire: General Business - May 29 2014]
Listing of bond loan(s) issued by Meda AB (publ... [Published GlobeNewswire: Acquisitions News - May 21 2014]
Meda AB (publ) AGM bulletin [Published Business Wire Health News - May 07 2014]
Meda AB (publ) AGM bulletin [Published GlobeNewswire: Advertising News - May 07 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Mission Pharmacal Begins Exclusive Promotion of... [Published PR Newswire: General Business - May 29 2014]
SAN ANTONIO, May 29, 2014 /PRNewswire/ -- Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is a prescription medicine approved by the Food and ...
Meda AB (publ) AGM bulletin [Published Business Wire Health News - May 07 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: At the annual general meeting (AGM) on May 7, 2014, of Meda AB (STO:MEDAA) (publ), corporate ID 556427-2812, Box 906, SE-170 09 Solna, Sweden, declared a dividend of 2,50 SEK per share. The AGM adopted ...
MEDA: Interim Report, January-March 2014 [Published Business Wire Health News - May 07 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda AB (STO:MEDAA): January-March 2014·The Group’s net sales reached SEK 3,365 million (3,199), corresponding to organic growth[1] of 3% compared to the previous year.·EBITDA was SEK 1,010 million (923), ...
ASTEPRO (Azelastine Hydrochloride) Spray, Meter... [Published DailyMed Drug Label Updates for the last seven ... - May 01 2014]
Updated Date: Apr 28, 2014 EST ...
Statement by the Board of Directors of Meda in ... [Published Business Wire Health News - Apr 28 2014]
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: This statement is made by the Board of Directors (the ”Board”) of Meda AB (publ) (”Meda”) (STO:MEDAA) pursuant to the Securities Markets Act and//or the Financial Instruments Trading Act. The Board hereby ...
1 2 3

Press Releases

sort by: Date | Relevance
Listing of bond loan(s) issued by Meda AB (publ... [Published GlobeNewswire: Acquisitions News - May 21 2014]
Meda AB (publ) AGM bulletin [Published GlobeNewswire: Advertising News - May 07 2014]
Statement by the Board of Directors of Meda in ... [Published GlobeNewswire: Acquisitions News - Apr 28 2014]
Meda and Valeant terminates joint ventures [Published GlobeNewswire: Advertising News - Apr 07 2014]
Statement by the Board of Directors of Meda [Published GlobeNewswire: Acquisitions News - Apr 04 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.